Song Young Bong, Lee Joon Hyoek, Choi Moon Seok, Koh Kwang Cheol, Paik Seung Woon, Yoo Byung Chul, Choi Yoon-Ho, Sohn Hee Jung, Lee Kyung Han, Rhee Jong Chul
Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Korean J Hepatol. 2007 Mar;13(1):27-33.
The epidemiology of hepatitis A is associated with socioeconomic and hygiene status. Recently, the prevalence of hepatitis A in young adults has been steadily increasing in Korea. This study is to investigate the age-specific seroprevalence of hepatitis A virus in Korea.
Stored sera from 250 healthy adult subjects who visited the health promotion center in Samsung Medical Center between July and August 2006 were tested for IgG hepatitis A virus antibody (anti-HAV).
The prevalence of anti-HAV was 2%, 72%, 92%, 94%, 100% in 20's, 30's, 40's, 50's, and 60's, respectively. The prevalence of anti-HAV was significantly lower in subjects below age 40 compared to those above 40 (37.0% vs. 95.3%, p<0.001). The seroprevalence was higher in area outside of Seoul compared to those living in Seoul in age group below 40 (25.6% vs. 55.6%, p=0.01). In Seoul area, the prevalence was significantly lower in Kangnam-Gu, Seocho-Gu, and Songpa-Gu district compared to the other areas of Seoul in the age group below 40 (20.0% vs. 42.1%, p<0.05).
The seroprevalence of hepatitis A virus antibody in Korean population below 40 is quite low and immunity to hepatitis A virus in those subjects can be a public health issue. In view of changing seroepidemiology, a policy for hepatitis A vaccination in population below 40 might be warranted.
甲型肝炎的流行病学与社会经济和卫生状况相关。最近,韩国青年成人中甲型肝炎的患病率一直在稳步上升。本研究旨在调查韩国甲型肝炎病毒的年龄特异性血清流行率。
对2006年7月至8月期间到三星医疗中心健康促进中心就诊的250名健康成人受试者的储存血清进行甲型肝炎病毒IgG抗体(抗-HAV)检测。
20多岁、30多岁、40多岁、50多岁和60多岁人群中抗-HAV的患病率分别为2%、72%、92%、94%、100%。40岁以下受试者的抗-HAV患病率显著低于40岁以上者(37.0%对95.3%,p<0.001)。40岁以下年龄组中,居住在首尔以外地区的人群血清流行率高于居住在首尔的人群(25.6%对55.6%,p=0.01)。在首尔地区,40岁以下年龄组中,江南区、瑞草区和松坡区的患病率显著低于首尔其他地区(20.0%对42.1%,p<0.05)。
40岁以下韩国人群中甲型肝炎病毒抗体的血清流行率相当低,这些人群对甲型肝炎病毒的免疫力可能是一个公共卫生问题。鉴于血清流行病学的变化,可能有必要对40岁以下人群制定甲型肝炎疫苗接种政策。